SS&C enters joint venture with Anthem and Humana to create cloud-based PBM platform DomaniRx

SS&C Technologies Holdings Inc

SS&C holds 80.2% stake; total committed capital up to $925M from partners.
Initial cash contributions of $138.3M plus license of RxNova claims platform.
DomaniRx to develop cloud-native, API-driven claims adjudication platform targeting PBM market.
Humana to be first customer; Anthem and Humana have exit rights under certain conditions.
Joint venture named DomaniRx LLC; SS&C to perform development and management services.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.